Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose celecoxib vs mefenamic acid for prophylaxis after tooth extraction
IRCT20220407054442N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of celecoxib and Mefenamic acid in postoperative pain and Inflammatory pain is not a disease; it is a symptom or type of pain associated with various inflammatory conditions (2 arms), sponsored by Shahrekord University of Medical Sciences. Started Jul 2022; status: completed.
02
Drugs
celecoxibMefenamic acid
03
Conditions
postoperative painInflammatory pain is not a disease; it is a symptom or type of pain associated with various inflammatory conditions.
Beyond the preview
Go deeper on IRCT20220407054442N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220407054442N1.